<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="ppub"/></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS191784</article-id><article-id pub-id-type="doi">10.1101/2023.11.25.568634</article-id><article-id pub-id-type="archive">PPR764900</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Evidence for a role of 5-HT-glutamate co-releasing neurons in acute stress mechanisms</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Gullino</surname><given-names>L. Sophie</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Fuller</surname><given-names>Cara</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Dunn</surname><given-names>Poppy</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Collins</surname><given-names>Helen M.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>El Mestikawy</surname><given-names>Salah</given-names></name><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Sharp</surname><given-names>Trevor</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib></contrib-group><aff id="A1"><label>1</label>University Department of Pharmacology, Mansfield Road, Oxford OX1 3QT, UK</aff><aff id="A2"><label>2</label>Douglas Mental Health University Institute, Department of Psychiatry, McGill University, Montreal, QC, H4H 1R3, Canada</aff><aff id="A3"><label>3</label>Sorbonne Université, INSERM, CNRS, Neuroscience Paris Seine – Institut de Biologie Paris Seine (NPS – IBPS), 75005 Paris, France</aff><pub-date pub-type="nihms-submitted"><day>27</day><month>11</month><year>2023</year></pub-date><pub-date pub-type="preprint"><day>25</day><month>11</month><year>2023</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">CC BY-NC 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P1">The majority of midbrain 5-hydroxytryptamine (5-HT) neurons express the vesicular glutamate transporter 3 (VGLUT3) and co-release 5-HT and glutamate, but the function of this co-release is unclear. Given the strong links between 5-HT and uncontrollable stress, we used a combination of c-Fos immunocytochemistry and conditional gene knock out in mice to test the hypothesis that glutamate co-releasing 5-HT neurons would be activated by stress and involved in stress coping.</p><p id="P2">Acute, uncontrollable swim stress increased c-Fos immunoreactivity in neurons co-expressing VGLUT3 and the 5-HT marker tryptophan hydroxylase 2 (TPH2) in the dorsal raphe nucleus (DRN). This effect was localised in the ventral DRN subregion and prevented by the antidepressant fluoxetine. In contrast, a more controllable stressor, acute social defeat, had no effect on c-Fos immunoreactivity in VGLUT3-TPH2 co-expressing neurons in the DRN.</p><p id="P3">To test whether activation of glutamate co-releasing 5-HT neurons was causally linked to stress coping, mice with a specific deletion of VGLUT3 in 5-HT neurons were exposed to acute swim stress. Compared to wildtype controls, the mutant mice showed increased climbing behaviour, a measure of active coping. Wildtype mice also showed increased climbing when administered fluoxetine, revealing an interesting parallel between the behavioural effects of genetic loss of VGLUT3 in 5-HT neurons and 5-HT reuptake inhibition.</p><p id="P4">We conclude that 5-HT-glutamate co-releasing neurons are recruited by exposure to uncontrollable stress. Furthermore, natural variation in the balance of 5-HT and glutamate released at the 5-HT synapse may impact on stress susceptibility.</p></abstract><kwd-group><kwd>5-HT</kwd><kwd>VGLUT3</kwd><kwd>glutamate</kwd><kwd>dorsal raphe nucleus</kwd><kwd>stress</kwd><kwd>c-Fos</kwd></kwd-group></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P5">Serotonin (5-hydroxytryptamine; 5-HT) is a key neuromodulator of emotional processing, stress sensitivity and coping behaviour<sup><xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R2">2</xref></sup>. 5-HT neurons in the midbrain dorsal raphe nucleus (DRN), the principal source of 5-HT innervation to the forebrain, are activated by acute inescapable stressors such as forced swim, restraint and foot-shock, as evident through increased expression of the activity-dependent immediate-early gene <italic>c-fos</italic> in 5-HT neurons<sup><xref ref-type="bibr" rid="R3">3</xref>–<xref ref-type="bibr" rid="R8">8</xref></sup>. Although other forms of stress also activate 5-HT neurons<sup><xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R10">10</xref></sup>, evidence suggests that stressors allowing for the least control (i.e. inescapable stressors) are associated with greater 5-HT neuron activation<sup><xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R11">11</xref>,<xref ref-type="bibr" rid="R12">12</xref></sup>.</p><p id="P6">Recently, it has become clear that 5-HT neurons are capable of releasing not only 5-HT but also glutamate. Electrophysiological evidence for 5-HT-glutamate co-release in cultured 5-HT neurons<sup><xref ref-type="bibr" rid="R13">13</xref></sup> was followed by the discovery of the expression of the type 3 vesicular glutamate transporter (VGLUT3) in the majority (50-80 %) of 5-HT neurons<sup><xref ref-type="bibr" rid="R14">14</xref>–<xref ref-type="bibr" rid="R16">16</xref></sup>. More recently, electrophysiological studies have demonstrated that optogenetic activation of 5-HT neurons elicits both 5-HT and glutamate-mediated synaptic responses in different forebrain regions<sup><xref ref-type="bibr" rid="R17">17</xref>–<xref ref-type="bibr" rid="R19">19</xref></sup>.</p><p id="P7">Currently the functional role of 5-HT-glutamate co-release is unclear although links to anxiety-like behaviour and reward processing have been proposed based on studies of the phenotype of VGLUT3 knockout mice<sup><xref ref-type="bibr" rid="R19">19</xref>–<xref ref-type="bibr" rid="R21">21</xref></sup> and the behavioural effects of optogenetic activation of 5-HT neurons<sup><xref ref-type="bibr" rid="R19">19</xref>,<xref ref-type="bibr" rid="R20">20</xref></sup>. Interestingly, in a recent chemogenetic study, activation of 5-HT neurons projecting to the prefrontal cortex from the ventral region of the DRN, an area rich in 5-HT-glutamate co-releasing neurons, increased active coping (i.e. reduced immobility) in mice exposed to swim stress<sup><xref ref-type="bibr" rid="R22">22</xref></sup>. The latter finding suggests that glutamate co-releasing 5-HT neurons are activated by uncontrollable stressors, such as swim stress, and may be involved in stress coping behaviour. This result<sup><xref ref-type="bibr" rid="R22">22</xref></sup> also emphasises the functional heterogeneity within DRN subregions that has been detected in previous studies<sup><xref ref-type="bibr" rid="R8">8</xref>,<xref ref-type="bibr" rid="R23">23</xref>,<xref ref-type="bibr" rid="R24">24</xref></sup>.</p><p id="P8">Here we used c-Fos immunohistochemistry to test the prediction that 5-HT-glutamate co-releasing neurons in the DRN (particularly the ventral region) would be activated by an uncontrollable stressor, specifically swim stress. Effects were compared with a more controllable stressor, acute social defeat. Finally, behavioural experiments using a novel transgenic mouse with VGLUT3 knockout targeted to 5-HT neurons (VGLUT3 cKO<sup>5-HT</sup> mice<sup><xref ref-type="bibr" rid="R25">25</xref></sup>) examined the causal link between changes in activity of 5-HT-glutamate co-releasing neurons and stress coping behaviour.</p></sec><sec id="S2" sec-type="results | discussion"><title>Results and Discussion</title><sec id="S3"><title>Swim stress evoked c-Fos expression in the DRN</title><p id="P9">Exposure of mice to acute swim stress increased the number of c-Fos immunoreactive neurons in the DRN and median raphe nucleus (MRN) (effect of treatment: F<sub>(2,17)</sub>=5.503, p=0.014; effect of region: F<sub>(1,15)</sub>=17.160, p&lt;0.001; region x treatment interaction: F<sub>(2,15)</sub>=0.272, p=0.766; <xref rid="F2" ref-type="fig">Fig. 2A</xref>). Post-hoc analysis revealed that this effect was statistically significant in the DRN of swim-stressed mice compared to non-stressed controls (p=0.017; <xref rid="F2" ref-type="fig">Fig. 2A</xref>). Conversely, the number of c-Fos immunoreactive cells in the MRN was not significantly different across conditions (F<sub>(2,15)</sub>=2.065, p=0.161; <xref rid="F2" ref-type="fig">Fig. 2A</xref>). These data are in accord with previous studies reporting that swim stress increased c-Fos immunoreactivity in DRN of rats<sup><xref ref-type="bibr" rid="R8">8</xref>,<xref ref-type="bibr" rid="R23">23</xref></sup>.</p><p id="P10">Further examination of the DRN at the subregional level (<xref rid="F2" ref-type="fig">Fig. 2B</xref>) revealed a statistically significant effect of both region (F<sub>(2,34)</sub>=5.884, p=0.006) and treatment (F<sub>(2,17)</sub>=5.721, p=0.013). Although the region x treatment interaction was not statistically significant (F<sub>(4,34)</sub>=1.512, p=0.221), likely due to the small sample size, post-hoc testing was deemed justified based on previous evidence and our a priori hypothesis of a preferential involvement of ventral DRN neurons in stress coping (see Introduction). Post-hoc analysis showed a statistically significant increase in c-Fos immunoreactive neurons in the ventral DRN of swim-stressed mice compared to non-stressed controls (p=0.002; <xref rid="F2" ref-type="fig">Fig. 2B</xref>), but non-significant effects in the dorsal DRN (p=0.181) and lateral wings (p=0.520). Pre-treatment with the selective serotonin reuptake inhibitor (SSRI) fluoxetine (10 mg/kg i.p.) prevented stress-induced c-Fos expression in the ventral DRN (post-hoc p=0.028; <xref rid="F2" ref-type="fig">Fig. 2B</xref>). Additionally, during swim stress fluoxetine-treated mice spent more time climbing, a measure of active coping (Mann-Whitney U=6, p=0.016; <bold><italic>Suppl. Fig. 1</italic></bold>; see later for further discussion).</p></sec><sec id="S4"><title>Swim stress increased c-Fos expression in DRN neurons co-expressing TPH2 and VGLUT3</title><p id="P11">Next, we investigated whether swim stress increased c-Fos immunoreactivity specifically in 5-HT-glutamate co-releasing neurons, using the same sections examined for c-Fos alone. Previous studies have revealed that VGLUT3-expressing neurons in the midbrain raphe nuclei comprise two sub-populations, one colocalizing 5-HT and the other lacking 5-HT<sup><xref ref-type="bibr" rid="R16">16</xref>,<xref ref-type="bibr" rid="R27">27</xref></sup>. Here, the 5-HT-specific marker tryptophan hydroxylase 2 (TPH2) was used to distinguish these two populations (<xref rid="F3" ref-type="fig">Fig. 3A</xref>). In agreement with these earlier studies, somatic VGLUT3 expression was particularly evident in TPH2 immunoreactive neurons located in the ventral DRN; thus, 67.9 ± 3.04 % of TPH2 immunoreactive neurons co-expressed VGLUT3 (<bold><italic>Suppl. Fig. 2</italic></bold>). In comparison, only sparse VGLUT3 expression was observed in TPH2 immunoreactive neurons in the dorsal DRN and lateral wings. Neurons with colocalised VGLUT3 and TPH2 were evident in the MRN although these neurons were less abundant than the DRN; thus, 34.9 ± 2.9 % of TPH2 immunoreactive neurons also expressed VGLUT3.</p><p id="P12">Importantly, swim stress increased the number of c-Fos/TPH2/VGLUT3 triple-labelled neurons in the ventral DRN compared to non-stressed controls (F<sub>(2,17)</sub>= 4.896, p=0.021, post-hoc p=0.036; <xref rid="F3" ref-type="fig">Fig. 3B</xref>). This effect of swim stress amounted to an increase in c-Fos in 32.3 ± 7 % of TPH2/VGLUT3 immunoreactive neurons in the ventral DRN. Furthermore, compared to saline controls pre-treatment with fluoxetine prevented the stress-induced increase in c-Fos immunoreactivity in TPH2/VGLUT3 co-expressing neurons (post-hoc p=0.042; <xref rid="F3" ref-type="fig">Fig. 3B</xref>).</p><p id="P13">Swim stress also significantly increased the number of c-Fos/TPH2 double-labelled neurons in the ventral DRN (F<sub>(2,17)</sub>=5.535, p=0.014, post-hoc p=0.034) compared to non-stressed controls (26.1 ± 2.8 % of TPH2 immunoreactive neurons), and this effect was also reduced by fluoxetine (F<sub>(2,17)</sub>=5.535, p=0.014, post-hoc p=0.023; <xref rid="F3" ref-type="fig">Fig. 3B</xref>). TPH2 immunoreactive neurons that were immunonegative for VGLUT3 did not show increased c-Fos expression in response to swim stress (F<sub>(2,17)</sub>= 2.115, p=0.151; <xref rid="F3" ref-type="fig">Fig. 3B</xref>). The number of TPH2 immunoreactive neurons did not differ between groups (<bold><italic>Suppl. Fig. 3A</italic></bold>).</p><p id="P14">To our knowledge this is the first report of evidence that 5-HT-glutamate co-releasing neurons in the ventral DRN are activated by exposure to a stressor, specifically acute swim stress. The inhibitory effect of fluoxetine on this stress-evoked response is in line with electrophysiological evidence that acute SSRI administration inhibits the firing of DRN 5-HT neurons through a 5-HT<sub>1A</sub> autoreceptor mediated hyperpolarisation<sup><xref ref-type="bibr" rid="R28">28</xref>–<xref ref-type="bibr" rid="R30">30</xref></sup>.</p></sec><sec id="S5"><title>Social defeat did not evoke c-Fos expression in DRN neurons co-expressing TPH2 and VGLUT3</title><p id="P15">Previous c-Fos studies report that 5-HT neurons in the DRN are more sensitive to uncontrollable versus controllable stressors<sup><xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R11">11</xref>,<xref ref-type="bibr" rid="R12">12</xref>,<xref ref-type="bibr" rid="R31">31</xref></sup>. Acute swim stress is a well-established inescapable stressor, whereas social defeat is an example of a more controllable stressor. Thus, socially-defeated animals adopt a variety of active coping strategies (e.g. flight, corner location, upright submissive postures) to minimise interactions with the opponent<sup><xref ref-type="bibr" rid="R32">32</xref></sup>.</p><p id="P16">We utilised the social defeat model to investigate the sensitivity of VGLUT3-expressing 5-HT neurons to a more controllable stressor. Here, naive intruder mice were exposed to a single episode of social defeat in the home cage of a larger territorially-dominant resident. Socially defeated mice were separated from the resident after a single defeat episode that was typically limited to less than a 1 min to avoid the stressor from becoming inescapable. The average latency for the resident to attack was 5.1 ± 1.7 s and the average number of attacks per encounter was 14.9 ± 2.8, i.e. an attack every 3 s, involving a combination of biting, kicking, and wrestling, prior to a clear pin down (social defeat). During the encounter intruder mice spent most of the time moving (90 ± 3.1 %) and actively avoiding the resident (distance travelled 3.4 ± 0.8 m).</p><p id="P17">Region-specific analysis showed that acute social defeat had no effect on the number of c-Fos immunoreactive neurons in the ventral DRN compared to non-stressed controls, and other DRN subregions were similarly unaffected (effect of region: F<sub>(1.815,24.50)</sub>=0.822, p=0.441, effect of treatment: F<sub>(1,14)</sub>=0.064, p=0.804, treatment x region interaction F<sub>(2, 27)</sub>= 1.123, p=0.340; <xref rid="F4" ref-type="fig">Fig. 4A</xref>). Moreover, the number of c-Fos/TPH2 double-labelled neurons in the ventral DRN was not different across groups (t<sub>(13)</sub>=1.158, p=0.403; <xref rid="F4" ref-type="fig">Fig. 4B</xref>). Importantly, and in contrast to swim stress, acute social defeat did not alter the number of c-Fos/TPH2/VGLUT3 triple-labelled neurons in the ventral DRN compared to non-stressed controls (t<sub>(13)</sub>=0.732, p=0.167; <xref rid="F4" ref-type="fig">Fig. 4B</xref>).</p><p id="P18">Social defeat also had no effect on c-Fos expression in TPH2 neurons which were VGLUT3 immunonegative (t<sub>(13)</sub>=1.167, p=0.264; <xref rid="F4" ref-type="fig">Fig. 4B</xref>), and the number of TPH2 immunoreactive neurons in the ventral DRN was also unchanged (<bold><italic>Suppl. Fig. 3B</italic></bold>).</p><p id="P19">The lack of effect of social defeat on c-Fos expression in the DRN is in line with previous studies exposing rodents to a single short (∼3 min) period of social defeat<sup><xref ref-type="bibr" rid="R33">33</xref>,<xref ref-type="bibr" rid="R34">34</xref></sup>. Although some studies report that acute social defeat increased c-Fos expression in DRN neurons<sup><xref ref-type="bibr" rid="R35">35</xref>,<xref ref-type="bibr" rid="R36">36</xref></sup>, these findings were obtained from animals exposed to the resident over a long period (∼10 min) such that the stressor likely becomes inescapable<sup><xref ref-type="bibr" rid="R33">33</xref></sup></p><p id="P20">Thus, the current data suggest that 5-HT-glutamate co-releasing neurons are preferentially activated by an uncontrollable versus controllable stressor. These data agree with previous c-Fos studies reporting that 5-HT neurons are more sensitive to uncontrollable versus controllable footshock<sup><xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R31">31</xref></sup> but extend the findings to 5-HT-glutamate co-releasing neurons. Based on previous experiments involving localised muscimol injections it was concluded that controllable stressors have less impact on DRN 5-HT neurons due to the inhibitory influence of the medial prefrontal cortex<sup><xref ref-type="bibr" rid="R11">11</xref></sup>. Thus, the greater effect of swim stress versus social defeat on VGLUT3-expressing 5-HT neurons could be explained by the same mechanism.</p><p id="P21">It could be argued that the lack of effect of social defeat on DRN neurons is due to the strength of the stressor being insufficient. However, social defeat increased c-Fos expression in the periaqueductal gray (PAG). Thus, in socially defeated mice, c-Fos expression increased in the dorsal PAG compared to non-stressed controls (effect of region: F<sub>(1,14)</sub>=181.4, p&lt;0.0001, effect of treatment: F<sub>(1,14)</sub>=10.20, p=0.007, region x treatment interaction: F<sub>(1,14)</sub>=8.358, p=0.012, post-hoc p=0.001; <xref rid="F5" ref-type="fig">Fig 5A</xref>), and there was a trend effect in the ventrolateral region (p=0.081). In comparison, swim stress also increased c-Fos expression in the dorsal and ventrolateral PAG (effect of region: F<sub>(1,10)</sub>=60.77, p&lt;0.0001, effect of treatment: F<sub>(1,10)</sub>=58.78, p&lt;0.0001, region x treatment interaction: F<sub>(1,10)</sub>=5.597, p=0.04, post-hoc p=0.001 and p&lt;0.0001; <xref rid="F5" ref-type="fig">Fig 5B</xref>). PAG sub-regions are well known to be activated by stress<sup><xref ref-type="bibr" rid="R37">37</xref></sup> and involved in stress coping<sup><xref ref-type="bibr" rid="R38">38</xref>,<xref ref-type="bibr" rid="R39">39</xref></sup>.</p></sec><sec id="S6"><title>Mice with VGLUT3-deficient 5-HT neurons showed increased climbing during swim stress</title><p id="P22">Finally, we tested the causal role of glutamate co-released from 5-HT neurons in stress coping behaviour using genetically modified mice with VGLUT3 deletion targeted to 5-HT neurons (VGLUT3 cKO<sup>5-HT</sup>; <sup><xref ref-type="bibr" rid="R25">25</xref></sup>). Specifically, we investigated the response of VGLUT3 cKO<sup>5-HT</sup> mice to swim stress using climbing as a measure of active coping behaviour<sup><xref ref-type="bibr" rid="R40">40</xref>–<xref ref-type="bibr" rid="R42">42</xref></sup>. Previous studies have shown this behaviour to be increased by SSRI treatment<sup><xref ref-type="bibr" rid="R41">41</xref>,<xref ref-type="bibr" rid="R43">43</xref></sup>.</p><p id="P23">Firstly, we confirmed a loss of VGLUT3 in the DRN of VGLUT3 cKO<sup>5-HT</sup> mice. Initial qPCR analysis demonstrated a 33.9 ± 5.7 % reduction of VGLUT3 mRNA in the midbrain raphe region of VGLUT3 cKO<sup>5-HT</sup> mice compared to wildtype controls (t<sub>(14)</sub>=3.734, p=0.002; <xref rid="F6" ref-type="fig">Fig 6B</xref>). This effect was selective in that the VGLUT3 cKO<sup>5-HT</sup> mice did not show altered expression of the vesicular monoamine transporter 2 (VMAT2) (t<sub>(14)</sub>=0.366, p=0.720; <xref rid="F6" ref-type="fig">Fig 6B</xref>). Then, immunocytochemistry confirmed a selective loss of VGLUT3 expression in DRN 5-HT neurons. Specifically, the number of TPH2/VGLUT3 co-labelled neurons in the ventral DRN of VGLUT3 cKO<sup>5-HT</sup> mice was reduced by 62.6 ± 4.8 % compared to wildtype controls (t<sub>(13)</sub>=7.879, p&lt;0.0001; <xref rid="F6" ref-type="fig">Fig. 6C</xref>). The TPH2 immunoreactive neuron count in the ventral DRN was not different between VGLUT3 cKO<sup>5-HT</sup> mice and wildtype controls (t<sub>(13)</sub>=1.365, p=0.195; <xref rid="F6" ref-type="fig">Fig 6C</xref>), suggesting that the genetic deletion did not impact on the total number of 5-HT neurons.</p><p id="P24">The incomplete depletion of VGLUT3 may reflect cross-reactivity of our antibody with non-functional VGLUT3 protein fragments that may be transcribed following the conditional knockout. Also, even though the distribution of immunolabelling with this antibody closely matched that of VGLUT3 mRNA reported in previous in situ hybridisation studies<sup><xref ref-type="bibr" rid="R27">27</xref></sup>, we cannot exclude the possibility of a low level of non-specific labelling.</p><p id="P25">Prior to the behavioural testing of VGLUT3 cKO<sup>5-HT</sup> mice we first established that pre-treatment of wildtype mice with fluoxetine increased time spent climbing when exposed to swim stress (Mann-Whitney U=6, p=0.016; <bold><italic>Suppl. Fig. 1</italic></bold>) as observed previously<sup><xref ref-type="bibr" rid="R41">41</xref>,<xref ref-type="bibr" rid="R43">43</xref></sup>. Perhaps surprisingly, fluoxetine had no effect on time spent immobile (Mann-Whitney U=15, p=0.259; <bold><italic>Suppl. Fig. 1</italic></bold>), but this has also been observed previously<sup><xref ref-type="bibr" rid="R42">42</xref>,<xref ref-type="bibr" rid="R44">44</xref></sup>. Although antidepressants normally reduce immobility in this paradigm, the C57BL/6 strain used here is generally less sensitive in this regard<sup><xref ref-type="bibr" rid="R45">45</xref>,<xref ref-type="bibr" rid="R46">46</xref></sup> Moreover, the current small swimming chamber dimensions are reported to make it difficult to detect changes in immobility behaviour<sup><xref ref-type="bibr" rid="R47">47</xref>,<xref ref-type="bibr" rid="R48">48</xref></sup>.</p><p id="P26">Interestingly, in parallel with the effects of fluoxetine, when exposed to swim stress VGLUT3 cKO<sup>5-HT</sup> mice also spent more time climbing versus littermate controls (Mann-Whitney U=77, p=0.042; <xref rid="F6" ref-type="fig">Fig. 6D</xref>) without having altered immobility time (Mann-Whitney U=131.5, p=0.917; <xref rid="F6" ref-type="fig">Fig 6D</xref>). Fluoxetine did not add further to the increase in climbing in the VGLUT3 cKO<sup>5-HT</sup> mice, potentially because of a ceiling effect. The increase in climbing behaviour in the VGLUT3 cKO<sup>5-HT</sup> mice was not associated with increased locomotor activity in that these mice showed similar levels of locomotion to their littermate controls in a separate locomotor test (effect of genotype: F<sub>(1, 34)</sub>=0.344, p=0.561; interaction: F<sub>(1, 34)</sub>=0.800, p=0.378; <xref rid="F6" ref-type="fig">Fig 6D</xref>).</p><p id="P27">The increase in climbing behaviour exhibited by VGLUT3 cKO<sup>5-HT</sup> mice is evidence of enhanced escape-driven active coping behaviour which typically characterises the initial response to swim stress exposure<sup><xref ref-type="bibr" rid="R40">40</xref></sup>. Given our above immunocytochemical evidence that swim stress activates 5-HT-glutamate co-releasing neurons, it seems as if a deficiency in co-released glutamate in VGLUT3 cKO<sup>5-HT</sup> mice promotes active coping behaviour. The predicted lack of co-released glutamate in the VGLUT3 cKO<sup>5-HT</sup> mice would theoretically shift the 5-HT/glutamate balance at the synapse in favour of 5-HT. Interestingly fluoxetine, which also increased climbing behaviour, would also shift the 5-HT/glutamate balance in favour of 5-HT by selectively inhibiting 5-HT reuptake<sup><xref ref-type="bibr" rid="R49">49</xref></sup>. In other words, a switch in 5-HT/glutamate balance in favour of 5-HT may promote active stress coping behaviour.</p><p id="P28">The latter idea is consistent with a recent report that chemogenetic activation of ventral DRN-prefrontal cortex projecting 5-HT neurons increased active coping in mice exposed to swim stress<sup><xref ref-type="bibr" rid="R22">22</xref></sup>. Although the latter manipulation might be expected to release both 5-HT and glutamate, electrophysiological evidence from optogenetic studies<sup><xref ref-type="bibr" rid="R18">18</xref></sup> suggests that 5-HT-glutamate co-release is frequency-dependent. This, glutamate was preferentially released at lower frequencies (1-2 Hz) and 5-HT was preferentially released at the higher frequencies (10-20 Hz). Therefore, chemogenetic activation may have preferentially released 5-HT resulting in increased active coping. Conversely, conditional TPH2 knockout from the same ventral DRN 5-HT neurons was found to increase immobility, supporting the hypothesis of the requirement for 5-HT in stress coping. Taken together, the evidence suggests that altered balance of 5-HT/glutamate in favour of 5-HT (i.e. away from glutamate and towards 5-HT-signalling pathways) may increase active coping and might therefore play a critical role in the behavioural response to stress.</p><p id="P29">A caveat of this hypothesis is the current lack of consensus regarding the mechanisms by which glutamate is co-released from 5-HT synapses<sup><xref ref-type="bibr" rid="R50">50</xref></sup>. The frequency-dependent nature of co-released glutamate and 5-HT evident in optogenetic studies<sup><xref ref-type="bibr" rid="R18">18</xref></sup> indicates that 5-HT and glutamate are released from different vesicular pools. On the other hand, co-release from the same vesicular pools has also been suggested based on synergism between VGLUT3 and VMAT2<sup><xref ref-type="bibr" rid="R50">50</xref></sup>. In the latter scenario, VGLUT3 would promote vesicular loading of 5-HT<sup><xref ref-type="bibr" rid="R51">51</xref></sup> in which case a reduction of VGLUT3 expression may decrease the vesicular content of both glutamate and 5-HT. Although this suggests that a loss of VGLUT3 in the VGLUT3 cKO<sup>5-HT</sup> mice might disrupt the balance of glutamate-5-HT co-release less than expected, it is difficult to reconcile an increase in stress coping with an overall decrease in release of 5-HT in these animals (e.g.<sup><xref ref-type="bibr" rid="R22">22</xref></sup>).</p><p id="P30">The theory that a shift in balance of 5-HT/glutamate in favour of 5-HT increases coping would have implications in situations where this balance is altered, for example by environmental or genetic factors affecting the expression of VGLUT3 (but also VMAT2 or SERT). Interestingly, evidence suggests that the level of 5-HT-glutamate co-release may not be fixed but rather is plastic. For instance, changes in VGLUT3 expression in 5-HT neurons have been reported in rats exposed to chronic stress<sup><xref ref-type="bibr" rid="R52">52</xref></sup> as well as during acquisition of generalised fear following acute stress<sup><xref ref-type="bibr" rid="R53">53</xref></sup>. More generally, VGLUT3 expression is reported to vary during neurodevelopment and early post-natal life<sup><xref ref-type="bibr" rid="R54">54</xref>,<xref ref-type="bibr" rid="R55">55</xref></sup>, and point mutations of the gene encoding VGLUT3 (Slc17a8) may result in a life-long alteration in VGLUT3 expression<sup><xref ref-type="bibr" rid="R56">56</xref></sup>. If the latter changes in VGLUT3 expression occur in 5-HT neurons and affect the balance of 5-HT-glutamate at the synapse, the present data suggest that they could impact on coping strategies and susceptibility to stress.</p></sec></sec><sec id="S7" sec-type="materials | methods"><title>Materials &amp; Methods</title><sec id="S8"><title>Animals</title><p id="P31">Mice were group housed (2-6 per cage) with littermates in individually ventilated cages, in a temperature-controlled room (21°C) with a 12 h light/dark cycle. Mice had <italic>ad libitum</italic> access to food and water, and cages were lined with sawdust bedding and contained cage enrichment (sizzle nests and a cardboard tube). Experiments were conducted during the light phase. Both female and male mice were used, except for the social defeat experiment which necessarily involved only males. Before each experiment mice were habituated to handling using a cardboard tunnel to minimise background stress<sup><xref ref-type="bibr" rid="R57">57</xref></sup>.</p><p id="P32">Most experiments utilised either C57BL/6J (Charles River, age 8-10 weeks) or transgenic mice with conditional VGLUT3 deletion targeted to 5-HT neurons (SERT-Cre::vGLUT3<sup>LoxP/LoxP</sup>, C57BL/<italic>6</italic>J background, age 8-17 weeks). The transgenic mice were generated by crossing VGLUT3<sup>loxP/loxP</sup> mice (carrying a floxed allele of the exon 2 of Slc17a8) with a serotonin transporter (SERT)-Cre line<sup><xref ref-type="bibr" rid="R25">25</xref></sup>. SERT-Cre::VGLUT3<sup>LoxP/LoxP</sup> were compared to control littermates (SERT<sup>+/ +</sup>::VGLUT3<sup>LoxP/LoxP</sup> or WT). Retired male breeder CD1 mice (Charles River, age 22-30 weeks) were employed as resident aggressor mice for the social defeat experiments.</p><p id="P33">Experiments followed the principles of the ARRIVE guidelines and were conducted according to the UK Animals (Scientific Procedures) Act of 1986 with appropriate personal and project licence coverage.</p></sec><sec id="S9"><title>Swim stress paradigm</title><p id="P34">Mice were randomly allocated to 1 of 3 experimental groups by stratified randomisation: i) saline; ii) saline + swim stress; and iii) fluoxetine (10 mg/kg) + swim stress. Mice were removed from their home cages and single-housed in a clean cage before and after undergoing a single exposure to swim stress. Saline or fluoxetine were injected i.p. 30 min prior to a swim stress.</p><p id="P35">During the last 5 min prior to swim stress, mice were placed in a clean but familiar cage, and their locomotor activity was recorded via an overhead camera for offline tracking using ANY-maze (Stoelting Europe) tracking software.</p><p id="P36">For swim stress, mice were placed individually for 6 min in a glass cylinder (height 25 cm, diameter 12 cm) containing water (height 20 cm) maintained at 20°C, as described previously<sup><xref ref-type="bibr" rid="R58">58</xref>,<xref ref-type="bibr" rid="R59">59</xref></sup>. A video camera was mounted in front of the cylinder and recordings were used for offline manual scoring by an experimenter blind to treatment. Climbing and immobility were timed during the final 4 min of stress exposure. Climbing was defined as placement of the front paws on the glass surface above water level<sup><xref ref-type="bibr" rid="R40">40</xref>,<xref ref-type="bibr" rid="R41">41</xref></sup>, whilst immobility was rated as the absence of escape-oriented behaviours. After the test, animals were towel-dried and placed in a heated cage until fully dry.</p><p id="P37">Ninety min after swim stress mice were deeply anesthetised prior to perfusion and collection of brain tissue for c-Fos immunohistochemistry (<xref rid="F7" ref-type="fig">Fig. 7</xref>). This timescale was chosen to allow for optimum c-Fos expression before tissue collection<sup><xref ref-type="bibr" rid="R60">60</xref></sup>.</p></sec><sec id="S10"><title>Social defeat paradigm</title><p id="P38">Male mice (C57BL/6J) were randomly allocated to two experimental groups by stratified randomisation: i) control and ii) social defeat. On the day of social defeat, mice were removed from their home cage and single-housed in a clean but familiar cage. Control mice remained in the clean cage for 90 min<sup><xref ref-type="bibr" rid="R61">61</xref></sup>. In the ‘social defeat’ condition, an intruder mouse was placed in the home cage of a territorially-dominant, aggressive resident mouse and subject to brief social defeat (as defined below). The intruder was then separated from the resident by a perforated acrylic partition which allowed auditory, visual, and olfactory interaction with the resident but no physical contact<sup><xref ref-type="bibr" rid="R61">61</xref></sup>. After 90 min mice were deeply anaesthetised and perfused (see below). The resident-intruder interaction was recorded with an overhead camera for offline behavioural analysis using ANY-maze software (Stoelting Europe).</p></sec><sec id="S11"><title>Resident mouse training and selection</title><p id="P39">Resident mice were selected based on a persistent level of aggression as previously described<sup><xref ref-type="bibr" rid="R61">61</xref></sup>. Briefly, on three consecutive days an intruder mouse was placed in the cage of a resident mouse for up to 3 min or until the latter was ‘socially defeated’. Social defeat was defined as a clear pin-down and/or a supine posture of the intruder. Each resident mouse interacted with a different intruder mouse daily. All interactions were filmed and video analysis of the latency to attack and number of attacks allowed selection of resident mice that consistently attacked within the first 20 s of the resident-intruder interaction.</p></sec><sec id="S12"><title>Immunohistochemistry and microscopy</title><p id="P40">Mice were deeply anesthetised by i.p. injection of with sodium pentobarbital (90 mg/kg; Euthatal) and intracardially perfused with 4 % paraformaldehyde in phosphate-buffered saline (PBS). Brains were then dissected, post-fixed by immersion in the same fixative for 48 h, cryoprotected in PBS containing 30 % sucrose and frozen at -80°C until sectioning.</p><p id="P41">Cryostat-cut coronal brain sections (30 μm; Bright LOFT cryostat) were taken at the level of the DRN (Bregma: -4.6<sup><xref ref-type="bibr" rid="R26">26</xref></sup> and stored in antifreeze (30 % glycerol, 30 % ethylene glycol, in PBS) at -20 °C prior to processing for immunohistochemistry as previously described<sup><xref ref-type="bibr" rid="R62">62</xref></sup>. In brief, sections were incubated overnight with the following primary antibodies: rabbit anti-c-Fos (1:1000, Abcam), goat anti-TPH2 (1:1000, Abcam), guinea pig anti-vGLUT3 (1:500 dilution, Synaptic Systems). The secondary antibodies used for protein visualization were the following: rabbit AF488 (1:1000, Invitrogen), guinea pig Cy3 (1:1000, Jackson Immune Research), goat AF647 (1:1000, Abcam). Cell nuclei were stained using DAPI (1:1000, 5 min).</p><p id="P42">Images were visualised using an epi-fluorescent microscope (Olympus BMAX BX40) and acquired with ImageJ Micromanager v1.4 (500 ms exposure). Sections were imaged at 20x magnification for the ventral DRN, dorsal DRN and MRN, and at 10x for the entire DRN, lateral wings, ventrolateral and dorsal PAG<sup><xref ref-type="bibr" rid="R26">26</xref></sup>. Cell counting and quantification of colocalization was performed by an experimenter blind to treatment employing the ImageJ Software package.</p><p id="P43">For each mouse, the mean cell count of 3 sections was used for statistical analysis. C-Fos immunoreactive cells with colocalised with DAPI immunoreactivity were defined as neurons. Colocalization of DAPI and TPH2 immunoreactivity identified 5-HT neurons, whist colocalization of TPH2 and VGLUT3 identified 5-HT-glutamate co-releasing neurons.</p></sec><sec id="S13"><title>Drugs</title><p id="P44">Fluoxetine hydrochloride (Stratech A2436-APE) was dissolved in 0.9 % sodium chloride in at 2 mg/ml and administered i.p. at a dose of 10 mg/kg. Control mice received saline in a volume of 2 ml/kg. All solutions were prepared fresh daily. Fluoxetine dose and administration protocol were based on previous studies<sup><xref ref-type="bibr" rid="R45">45</xref>,<xref ref-type="bibr" rid="R46">46</xref></sup>.</p></sec><sec id="S14"><title>qPCR analysis</title><p id="P45">For PCR analysis, the midbrain raphe region was dissected from frozen tissue sections (1 mm). RNA was extracted (Qiagen RNeasy Mini Kit) using the TRIzol method<sup><xref ref-type="bibr" rid="R63">63</xref></sup> and eluted into 20 μl of RNase-free water. DNA conversion and qPCR were conducted as described previously<sup><xref ref-type="bibr" rid="R64">64</xref></sup>. In brief, conversion to cDNA was achieved using a high-capacity cDNA Reverse Transcription Kit (Life Technologies) and T100 Thermocycler (Bio-Rad). QPCR was performed (800 ng RNA) using a LightCycler® 480 instrument (Roche Diagnostics) with the following primers (300 nM): VGLUT3 (specifically targeting the exon 2) 5’-CGATGGGACCAATGAAGAGGA-3’ and 5’-CAGTCACAGACAGGGCGATG-3; VMAT2 5’-CATCACGCAGACTTGAAAGAC-3’ and 5’-CGCCTCGCCTTGCTTATCC-3’<sup><xref ref-type="bibr" rid="R65">65</xref></sup>. GAPDH was used as the reference gene (Santa Cruz Biotechnology). Reactions (384 well-plates, 10 μl reaction volume, 5 μl Precision®PLUS qPCR Master Mix with SYBRgreen, 25 ng cDNA) used the following cycle: enzyme activation for 2 min at 95 °C, 40 cycles of 10 s at 95 °C, 1 min at 60 °C, then held at 4 °C. Samples were run in triplicate and 2<sup>-ΔΔCT</sup> was calculated for each sample, where ΔCT = CT<sub>target gene</sub> – CT<sub>reference gene</sub>. Data were analysed as fold-change in gene expression relative to the control group.</p></sec><sec id="S15"><title>Statistical Analysis</title><p id="P46">The Shapiro-Wilk test for normality was applied to all data sets. If data were normally distributed, then a t-test, one-way or two-way ANOVA were used followed by Tukey’s or Šídák’s post hoc tests as appropriate. Specifically, when c-Fos data was analysed across multiple regions, repeated-measures two-way ANOVA was employed for balanced data whereas a repeated-measure mixed-effect model was used for datasets with missing values. If the data were non-parametric then a single or multiple Mann-Whitney test was employed, with Holm-Šídák correction for multiple comparison. GraphPad Prism was used for all analysis and plotting of graphs. Parametric data are presented as mean ± standard error of the mean (SEM) values, whilst non-parametric data are presented as median ± interquartile range values; p&lt;0.05 was considered statistically significant.</p></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary information</label><media xlink:href="EMS191784-supplement-Supplementary_information.pdf" mimetype="application" mime-subtype="pdf" id="d11aAdDbB" position="anchor"/></supplementary-material></sec></body><back><ack id="S16"><title>Acknowledgments</title><p>SG was supported by a studentship from the Oxford-MRC Doctoral Training Programme. HC was supported by a Wellcome Trust PhD Studentship in Basic Science (HC; grant no. 219982/Z/19/Z).</p></ack><fn-group><fn id="FN1" fn-type="con"><p id="P47"><bold>Author information</bold></p><p id="P48">SG performed experiments, analysed the data, and contributed to writing the manuscript. CF and PD performed <italic>ex vivo</italic> tissue analysis. HC contributed to behavioural experiments. SEM contributed to manuscript preparation. TS contributed to the conception and design of the work, drafting, and revising the manuscript, and interpretation of data.</p></fn></fn-group><glossary><title>Abbreviations</title><def-list><def-item><term>5-HT</term><def><p>5-hydroxytryptamine</p></def></def-item><def-item><term>DRN</term><def><p>dorsal raphe nucleus</p></def></def-item><def-item><term>FLX</term><def><p>fluoxetine</p></def></def-item><def-item><term>MRN</term><def><p>median raphe nucleus</p></def></def-item><def-item><term>PAG</term><def><p>periaqueductal gray</p></def></def-item><def-item><term>SSRI</term><def><p>serotonin reuptake inhibitor</p></def></def-item><def-item><term>TPH2</term><def><p>tryptophan hydroxylase 2</p></def></def-item><def-item><term>VGLUT3</term><def><p>vesicular glutamate transporter 3</p></def></def-item><def-item><term>VMAT2</term><def><p>vesicular monoamine transporter 2</p></def></def-item></def-list></glossary><ref-list><ref id="R1"><label>(1)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaouloff</surname><given-names>F</given-names></name><name><surname>Berton</surname><given-names>O</given-names></name><name><surname>Mormède</surname><given-names>P</given-names></name></person-group><article-title>Serotonin and Stress</article-title><source>Neuropsychopharmacology</source><year>1999</year><volume>21</volume><issue>1</issue><fpage>28</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">10432486</pub-id></element-citation></ref><ref id="R2"><label>(2)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cools</surname><given-names>R</given-names></name><name><surname>Roberts</surname><given-names>AC</given-names></name><name><surname>Robbins</surname><given-names>TW</given-names></name></person-group><article-title>Serotoninergic Regulation of Emotional and Behavioural Control Processes</article-title><source>Trends Cogn Sci</source><year>2008</year><volume>12</volume><issue>1</issue><fpage>31</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">18069045</pub-id></element-citation></ref><ref id="R3"><label>(3)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roche</surname><given-names>M</given-names></name><name><surname>Commons</surname><given-names>KG</given-names></name><name><surname>Peoples</surname><given-names>A</given-names></name><name><surname>Valentino</surname><given-names>RJ</given-names></name></person-group><article-title>Circuitry Underlying Regulation of the Serotonergic System by Swim Stress</article-title><source>Journal of Neuroscience</source><year>2003</year><volume>23</volume><issue>3</issue><fpage>970</fpage><lpage>977</lpage><pub-id pub-id-type="pmcid">PMC6741925</pub-id><pub-id pub-id-type="pmid">12574426</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.23-03-00970.2003</pub-id></element-citation></ref><ref id="R4"><label>(4)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silveira</surname><given-names>MCL</given-names></name><name><surname>Sandner</surname><given-names>G</given-names></name><name><surname>Graeff</surname><given-names>FG</given-names></name></person-group><article-title>Induction of Fos Immunoreactivity in the Brain by Exposure to the Elevated Plus-Maze</article-title><source>Behavioural Brain Research</source><year>1993</year><volume>56</volume><issue>1</issue><fpage>115</fpage><lpage>118</lpage><pub-id pub-id-type="pmid">8397853</pub-id></element-citation></ref><ref id="R5"><label>(5)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Senba</surname><given-names>E</given-names></name><name><surname>Matsunaga</surname><given-names>K</given-names></name><name><surname>Tohyama</surname><given-names>M</given-names></name><name><surname>Noguchi</surname><given-names>K</given-names></name></person-group><article-title>Stress-Induced c-Fos Expression in the Rat Brain: Activation Mechanism of Sympathetic Pathway</article-title><source>Brain Res Bull</source><year>1993</year><volume>31</volume><issue>3</issue><fpage>329</fpage><lpage>344</lpage><pub-id pub-id-type="pmid">8490732</pub-id></element-citation></ref><ref id="R6"><label>(6)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hale</surname><given-names>MW</given-names></name><name><surname>Hay-Schmidt</surname><given-names>A</given-names></name><name><surname>Mikkelsen</surname><given-names>JD</given-names></name><name><surname>Poulsen</surname><given-names>B</given-names></name><name><surname>Bouwknecht</surname><given-names>JA</given-names></name><name><surname>Evans</surname><given-names>AK</given-names></name><name><surname>Stamper</surname><given-names>CE</given-names></name><name><surname>Shekhar</surname><given-names>A</given-names></name><name><surname>Lowry</surname><given-names>CA</given-names></name></person-group><article-title>Exposure to an Open-Field Arena Increases c-Fos Expression in a Subpopulation of Neurons in the Dorsal Raphe Nucleus, Including Neurons Projecting to the Basolateral Amygdaloid Complex</article-title><source>Neuroscience</source><year>2008</year><volume>157</volume><issue>4</issue><fpage>733</fpage><lpage>748</lpage><pub-id pub-id-type="pmcid">PMC3072241</pub-id><pub-id pub-id-type="pmid">18951955</pub-id><pub-id pub-id-type="doi">10.1016/j.neuroscience.2008.09.050</pub-id></element-citation></ref><ref id="R7"><label>(7)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonapersona</surname><given-names>V</given-names></name><name><surname>Schuler</surname><given-names>H</given-names></name><name><surname>Damsteegt</surname><given-names>R</given-names></name><name><surname>Adolfs</surname><given-names>Y</given-names></name><name><surname>Pasterkamp</surname><given-names>RJ</given-names></name><name><surname>Van Den Heuvel</surname><given-names>MP</given-names></name><name><surname>Joëls</surname><given-names>M</given-names></name><name><surname>Sarabdjitsingh</surname><given-names>RA</given-names></name></person-group><article-title>The Mouse Brain after Foot Shock in Four Dimensions: Temporal Dynamics at a Single-Cell Resolution</article-title><source>Proceedings of the National Academy of Sciences</source><year>2022</year><volume>119</volume><issue>8</issue><elocation-id>e2114002119</elocation-id><pub-id pub-id-type="pmcid">PMC8872757</pub-id><pub-id pub-id-type="pmid">35181604</pub-id><pub-id pub-id-type="doi">10.1073/pnas.2114002119</pub-id></element-citation></ref><ref id="R8"><label>(8)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>KJ</given-names></name><name><surname>Donner</surname><given-names>NC</given-names></name><name><surname>Hale</surname><given-names>MW</given-names></name><name><surname>Lowry</surname><given-names>CA</given-names></name></person-group><article-title>Swim Stress Activates Serotonergic and Nonserotonergic Neurons in Specific Subdivisions of the Rat Dorsal Raphe Nucleus in a Temperature-Dependent Manner</article-title><source>Neuroscience</source><year>2011</year><volume>197</volume><fpage>251</fpage><lpage>268</lpage><pub-id pub-id-type="pmcid">PMC3219528</pub-id><pub-id pub-id-type="pmid">21945646</pub-id><pub-id pub-id-type="doi">10.1016/j.neuroscience.2011.09.011</pub-id></element-citation></ref><ref id="R9"><label>(9)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amat</surname><given-names>J</given-names></name><name><surname>Matus-Amat</surname><given-names>P</given-names></name><name><surname>Watkins</surname><given-names>LR</given-names></name><name><surname>Maier</surname><given-names>SF</given-names></name></person-group><article-title>Escapable and Inescapable Stress Differentially and Selectively Alter Extracellular Levels of 5-HT in the Ventral Hippocampus and Dorsal Periaqueductal Gray of the Rat</article-title><source>Brain Res</source><year>1998</year><volume>797</volume><fpage>12</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">9630480</pub-id></element-citation></ref><ref id="R10"><label>(10)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>EHY</given-names></name><name><surname>Lin</surname><given-names>HH</given-names></name><name><surname>Yin</surname><given-names>HM</given-names></name><name><surname>Lee</surname><given-names>EHY</given-names></name></person-group><article-title>Differential Influences of Different Stressors upon Midbrain Raphe Neurons in Rats</article-title><source>Neurosci Lett</source><year>1987</year><volume>80</volume><fpage>115</fpage><lpage>134</lpage><pub-id pub-id-type="pmid">2443877</pub-id></element-citation></ref><ref id="R11"><label>(11)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amat</surname><given-names>J</given-names></name><name><surname>Baratta</surname><given-names>MV</given-names></name><name><surname>Paul</surname><given-names>E</given-names></name><name><surname>Bland</surname><given-names>ST</given-names></name><name><surname>Watkins</surname><given-names>LR</given-names></name><name><surname>Maier</surname><given-names>SF</given-names></name></person-group><article-title>Medial Prefrontal Cortex Determines How Stressor Controllability Affects Behavior and Dorsal Raphe Nucleus</article-title><source>Nat Neurosci</source><year>2005</year><volume>8</volume><issue>3</issue><fpage>365</fpage><lpage>371</lpage><pub-id pub-id-type="pmid">15696163</pub-id></element-citation></ref><ref id="R12"><label>(12)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maier</surname><given-names>SF</given-names></name><name><surname>Watkins</surname><given-names>LR</given-names></name></person-group><article-title>Stressor Controllability and Learned Helplessness: The Roles of the Dorsal Raphe Nucleus, Serotonin, and Corticotropin-Releasing Factor</article-title><source>Neurosci Biobehav Rev</source><year>2005</year><volume>29</volume><issue>4–5</issue><fpage>829</fpage><lpage>841</lpage><pub-id pub-id-type="pmid">15893820</pub-id></element-citation></ref><ref id="R13"><label>(13)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>MD</given-names></name></person-group><article-title>Synaptic Glutamate Release by Postnatal Rat Serotonergic Neurons in Microculture</article-title><source>Neuron</source><year>1994</year><volume>12</volume><issue>2</issue><fpage>433</fpage><lpage>442</lpage><pub-id pub-id-type="pmid">7906530</pub-id></element-citation></ref><ref id="R14"><label>(14)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schäfer</surname><given-names>MKH</given-names></name><name><surname>Varoqui</surname><given-names>H</given-names></name><name><surname>Defamie</surname><given-names>N</given-names></name><name><surname>Weihe</surname><given-names>E</given-names></name><name><surname>Erickson</surname><given-names>JD</given-names></name></person-group><article-title>Molecular Cloning and Functional Identification of Mouse Vesicular Glutamate Transporter 3 and Its Expression in Subsets of Novel Excitatory Neurons</article-title><source>Journal of Biological Chemistry</source><year>2002</year><volume>277</volume><issue>52</issue><fpage>50734</fpage><lpage>50748</lpage><pub-id pub-id-type="pmid">12384506</pub-id></element-citation></ref><ref id="R15"><label>(15)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gras</surname><given-names>C</given-names></name><name><surname>Herzog</surname><given-names>E</given-names></name><name><surname>Bellenchi</surname><given-names>GC</given-names></name><name><surname>Ronique Bernard</surname><given-names>V</given-names></name><name><surname>Ravassard</surname><given-names>P</given-names></name><name><surname>Pohl</surname><given-names>M</given-names></name><name><surname>Gasnier</surname><given-names>B</given-names></name><name><surname>Giros</surname><given-names>B</given-names></name><name><surname>Mestikawy</surname><given-names>S</given-names></name></person-group><article-title>El</article-title><source>A Third Vesicular Glutamate Transporter Expressed by Cholinergic and Serotoninergic Neurons</source><year>2002</year><volume>22</volume><issue>13</issue><elocation-id>5442-545.1</elocation-id><pub-id pub-id-type="pmcid">PMC6758212</pub-id><pub-id pub-id-type="pmid">12097496</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.22-13-05442.2002</pub-id></element-citation></ref><ref id="R16"><label>(16)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fremeau</surname><given-names>RT</given-names></name><name><surname>Burman</surname><given-names>J</given-names></name><name><surname>Qureshi</surname><given-names>T</given-names></name><name><surname>Tran</surname><given-names>CH</given-names></name><name><surname>Proctor</surname><given-names>J</given-names></name><name><surname>Johnson</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Sulzer</surname><given-names>D</given-names></name><name><surname>Copenhagen</surname><given-names>DR</given-names></name><name><surname>Storm-Mathisen</surname><given-names>J</given-names></name><name><surname>Reimer</surname><given-names>RJ</given-names></name><etal/></person-group><article-title>The Identification of Vesicular Glutamate Transporter 3 Suggests Novel Modes of Signaling by Glutamate</article-title><source>Proceedings National Academy of Sciences</source><year>2002</year><volume>99</volume><issue>2</issue><fpage>14488</fpage><lpage>14493</lpage><pub-id pub-id-type="pmcid">PMC137910</pub-id><pub-id pub-id-type="pmid">12388773</pub-id><pub-id pub-id-type="doi">10.1073/pnas.222546799</pub-id></element-citation></ref><ref id="R17"><label>(17)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varga</surname><given-names>V</given-names></name><name><surname>Losonczy</surname><given-names>A</given-names></name><name><surname>Zemelman</surname><given-names>BV</given-names></name><name><surname>Borhegyi</surname><given-names>Z</given-names></name><name><surname>Nyiri</surname><given-names>G</given-names></name><name><surname>Domonkos</surname><given-names>A</given-names></name><name><surname>Hangya</surname><given-names>B</given-names></name><name><surname>Holderith</surname><given-names>N</given-names></name><name><surname>Magee</surname><given-names>JC</given-names></name><name><surname>Freund</surname><given-names>TF</given-names></name></person-group><article-title>Fast Synaptic Subcortical Control of Hippocampal Circuits</article-title><source>Science (1979)</source><year>2009</year><volume>326</volume><issue>5951</issue><fpage>449</fpage><lpage>453</lpage><pub-id pub-id-type="pmid">19833972</pub-id></element-citation></ref><ref id="R18"><label>(18)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sengupta</surname><given-names>A</given-names></name><name><surname>Bocchio</surname><given-names>M</given-names></name><name><surname>Bannerman</surname><given-names>DM</given-names></name><name><surname>Sharp</surname><given-names>T</given-names></name><name><surname>Capogna</surname><given-names>M</given-names></name></person-group><article-title>Control of Amygdala Circuits by 5-HT Neurons via 5-HT and Glutamate Cotransmission</article-title><source>The Journal of Neuroscience</source><year>2017</year><volume>37</volume><issue>7</issue><fpage>1785</fpage><pub-id pub-id-type="pmcid">PMC5320609</pub-id><pub-id pub-id-type="pmid">28087766</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2238-16.2016</pub-id></element-citation></ref><ref id="R19"><label>(19)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>F</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>M</given-names></name><name><surname>Feng</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>Jen</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Zeng</surname><given-names>J</given-names></name><name><surname>Bao</surname><given-names>J</given-names></name><etal/></person-group><article-title>Dorsal Raphe Neurons Signal Reward through 5-HT and Glutamate</article-title><source>Neuron</source><year>2014</year><volume>81</volume><issue>6</issue><fpage>1360</fpage><lpage>1374</lpage><pub-id pub-id-type="pmcid">PMC4411946</pub-id><pub-id pub-id-type="pmid">24656254</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2014.02.010</pub-id></element-citation></ref><ref id="R20"><label>(20)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>HL</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Qi</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Cachope</surname><given-names>R</given-names></name><name><surname>Mejias-Aponte</surname><given-names>CA</given-names></name><name><surname>Gomez</surname><given-names>JA</given-names></name><name><surname>Mateo-Semidey</surname><given-names>GE</given-names></name><name><surname>Beaudoin</surname><given-names>GMJ</given-names></name><name><surname>Paladini</surname><given-names>CA</given-names></name><name><surname>Cheer</surname><given-names>JF</given-names></name><etal/></person-group><article-title>Dorsal Raphe Dual Serotonin-Glutamate Neurons Drive Reward by Establishing Excitatory Synapses on VTA Mesoaccumbens Dopamine Neurons</article-title><source>Cell Rep</source><year>2019</year><volume>26</volume><issue>5</issue><fpage>1128</fpage><lpage>1142</lpage><elocation-id>e7</elocation-id><pub-id pub-id-type="pmcid">PMC6489450</pub-id><pub-id pub-id-type="pmid">30699344</pub-id><pub-id pub-id-type="doi">10.1016/j.celrep.2019.01.014</pub-id></element-citation></ref><ref id="R21"><label>(21)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amilhon</surname><given-names>B</given-names></name><name><surname>Lepicard</surname><given-names>È</given-names></name><name><surname>Renoir</surname><given-names>T</given-names></name><name><surname>Mongeau</surname><given-names>R</given-names></name><name><surname>Popa</surname><given-names>D</given-names></name><name><surname>Poirel</surname><given-names>O</given-names></name><name><surname>Miot</surname><given-names>S</given-names></name><name><surname>Gras</surname><given-names>C</given-names></name><name><surname>Gardier</surname><given-names>AM</given-names></name><name><surname>Gallego</surname><given-names>J</given-names></name><name><surname>Hamon</surname><given-names>M</given-names></name><etal/></person-group><article-title>VGLUT3 (Vesicular Glutamate Transporter Type 3) Contribution to the Regulation of Serotonergic Transmission and Anxiety</article-title><source>Journal of Neuroscience</source><year>2010</year><volume>30</volume><issue>6</issue><fpage>2198</fpage><lpage>2210</lpage><pub-id pub-id-type="pmcid">PMC6634029</pub-id><pub-id pub-id-type="pmid">20147547</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5196-09.2010</pub-id></element-citation></ref><ref id="R22"><label>(22)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>J</given-names></name><name><surname>Friedmann</surname><given-names>D</given-names></name><name><surname>Xiong</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>CD</given-names></name><name><surname>Ferguson</surname><given-names>BR</given-names></name><name><surname>Weerakkody</surname><given-names>T</given-names></name><name><surname>DeLoach</surname><given-names>KE</given-names></name><name><surname>Ran</surname><given-names>C</given-names></name><name><surname>Pun</surname><given-names>A</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Weissbourd</surname><given-names>B</given-names></name><etal/></person-group><article-title>Anatomically Defined and Functionally Distinct Dorsal Raphe Serotonin Sub-Systems</article-title><source>Cell</source><year>2018</year><volume>175</volume><issue>2</issue><fpage>472</fpage><lpage>487</lpage><elocation-id>e20</elocation-id><pub-id pub-id-type="pmcid">PMC6173627</pub-id><pub-id pub-id-type="pmid">30146164</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2018.07.043</pub-id></element-citation></ref><ref id="R23"><label>(23)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hale</surname><given-names>MW</given-names></name><name><surname>Shekhar</surname><given-names>A</given-names></name><name><surname>Lowry</surname><given-names>CA</given-names></name></person-group><article-title>Stress-Related Serotonergic Systems: Implications for Symptomatology of Anxiety and Affective Disorders</article-title><source>Cell Mol Neurobiol</source><year>2012</year><volume>32</volume><issue>5</issue><fpage>695</fpage><lpage>708</lpage><pub-id pub-id-type="pmcid">PMC3378822</pub-id><pub-id pub-id-type="pmid">22484834</pub-id><pub-id pub-id-type="doi">10.1007/s10571-012-9827-1</pub-id></element-citation></ref><ref id="R24"><label>(24)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowry</surname><given-names>CA</given-names></name><name><surname>Johnson</surname><given-names>PL</given-names></name><name><surname>Hay-Schmidt</surname><given-names>A</given-names></name><name><surname>Mikkelsen</surname><given-names>J</given-names></name><name><surname>Shekhar</surname><given-names>A</given-names></name></person-group><article-title>Modulation of Anxiety Circuits by Serotonergic Systems</article-title><source>Stress</source><year>2005</year><volume>8</volume><issue>4</issue><fpage>233</fpage><lpage>246</lpage><pub-id pub-id-type="pmid">16423712</pub-id></element-citation></ref><ref id="R25"><label>(25)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansouri-Guilani</surname><given-names>N</given-names></name><name><surname>Bernard</surname><given-names>V</given-names></name><name><surname>Vigneault</surname><given-names>E</given-names></name><name><surname>Vialou</surname><given-names>V</given-names></name><name><surname>Daumas</surname><given-names>S</given-names></name><name><surname>El Mestikawy</surname><given-names>S</given-names></name><name><surname>Gangarossa</surname><given-names>G</given-names></name></person-group><article-title>VGLUT3 Gates Psychomotor Effects Induced by Amphetamine</article-title><source>J Neurochem</source><year>2019</year><volume>148</volume><issue>6</issue><fpage>779</fpage><lpage>795</lpage><pub-id pub-id-type="pmid">30556914</pub-id></element-citation></ref><ref id="R26"><label>(26)</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Paxinos</surname><given-names>G</given-names></name><name><surname>Franklin</surname><given-names>KBJ</given-names></name></person-group><source>The Mouse Brain in Stereotaxic Coordinates</source><publisher-name>Academic Press</publisher-name><year>2001</year><fpage>296</fpage></element-citation></ref><ref id="R27"><label>(27)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hioki</surname><given-names>H</given-names></name><name><surname>Nakamura</surname><given-names>H</given-names></name><name><surname>Ma</surname><given-names>YF</given-names></name><name><surname>Konno</surname><given-names>M</given-names></name><name><surname>Hayakawa</surname><given-names>T</given-names></name><name><surname>Nakamura</surname><given-names>KC</given-names></name><name><surname>Fujiyama</surname><given-names>F</given-names></name><name><surname>Kaneko</surname><given-names>T</given-names></name></person-group><article-title>Vesicular Glutamate Transporter 3-Expressing Nonserotonergic Projection Neurons Constitute a Subregion in the Rat Midbrain Raphe Nuclei</article-title><source>Journal of Comparative Neurology</source><year>2010</year><volume>518</volume><issue>5</issue><fpage>668</fpage><lpage>686</lpage><pub-id pub-id-type="pmid">20034056</pub-id></element-citation></ref><ref id="R28"><label>(28)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasmussen</surname><given-names>K</given-names></name><name><surname>McCreary</surname><given-names>AC</given-names></name><name><surname>Shanks</surname><given-names>EA</given-names></name></person-group><article-title>Attenuation of the Effects of Fluoxetine on Serotonergic Neuronal Activity by Pindolol in Rats</article-title><source>Neurosci Lett</source><year>2004</year><volume>355</volume><issue>1–2</issue><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">14729220</pub-id></element-citation></ref><ref id="R29"><label>(29)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Mansari</surname><given-names>M</given-names></name><name><surname>Sánchez</surname><given-names>C</given-names></name><name><surname>Chouvet</surname><given-names>G</given-names></name><name><surname>Renaud</surname><given-names>B</given-names></name><name><surname>Haddjeri</surname><given-names>N</given-names></name></person-group><article-title>Effects of Acute and Long-Term Administration of Escitalopram and Citalopram on Serotonin Neurotransmission: An in Vivo Electrophysiological Study in Rat Brain</article-title><source>Neuropsychopharmacology</source><year>2005</year><volume>30</volume><issue>7</issue><fpage>1269</fpage><lpage>1277</lpage><pub-id pub-id-type="pmid">15702136</pub-id></element-citation></ref><ref id="R30"><label>(30)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gartside</surname><given-names>SE</given-names></name><name><surname>Umbers</surname><given-names>V</given-names></name><name><surname>Hajós</surname><given-names>M</given-names></name><name><surname>Sharp</surname><given-names>T</given-names></name></person-group><article-title>Interaction between a Selective 5-HT1A Receptor Antagonist and an SSRI in Vivo: Effects on 5-HT Cell Firing and Extracellular 5-HT</article-title><source>Br J Pharmacol</source><year>1995</year><volume>115</volume><issue>6</issue><fpage>1064</fpage><lpage>1070</lpage><pub-id pub-id-type="pmcid">PMC1909022</pub-id><pub-id pub-id-type="pmid">7582504</pub-id><pub-id pub-id-type="doi">10.1111/j.1476-5381.1995.tb15919.x</pub-id></element-citation></ref><ref id="R31"><label>(31)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grahn</surname><given-names>RE</given-names></name><name><surname>Will</surname><given-names>MJ</given-names></name><name><surname>Hammack</surname><given-names>SE</given-names></name><name><surname>Maswood</surname><given-names>S</given-names></name><name><surname>Mcqueen</surname><given-names>MB</given-names></name><name><surname>Watkins</surname><given-names>LR</given-names></name><name><surname>Maier</surname><given-names>SF</given-names></name></person-group><article-title>Activation of Serotonin-Immunoreactive Cells in the Dorsal Raphe Nucleus in Rats Exposed to an Uncontrollable Stressor</article-title><source>Brain Res</source><year>1999</year><volume>826</volume><fpage>35</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">10216194</pub-id></element-citation></ref><ref id="R32"><label>(32)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diaz</surname><given-names>V</given-names></name><name><surname>Lin</surname><given-names>D</given-names></name></person-group><article-title>Neural Circuits for Coping with Social Defeat</article-title><source>Curr Opin Neurobiol</source><year>2020</year><volume>60</volume><fpage>99</fpage><lpage>107</lpage><pub-id pub-id-type="pmcid">PMC7002193</pub-id><pub-id pub-id-type="pmid">31837481</pub-id><pub-id pub-id-type="doi">10.1016/j.conb.2019.11.016</pub-id></element-citation></ref><ref id="R33"><label>(33)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuda</surname><given-names>S</given-names></name><name><surname>Peng</surname><given-names>H</given-names></name><name><surname>Yoshimura</surname><given-names>H</given-names></name><name><surname>Wen</surname><given-names>C</given-names></name><name><surname>Fukuda</surname><given-names>T</given-names></name><name><surname>Sakanaka</surname><given-names>M</given-names></name></person-group><article-title>Persistent C-Fos Expression in the Brains of Mice with Chronic Social Stress</article-title><source>Neurosci Res</source><year>1996</year><volume>26</volume><fpage>157</fpage><lpage>170</lpage><pub-id pub-id-type="pmid">8953578</pub-id></element-citation></ref><ref id="R34"><label>(34)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname><given-names>M</given-names></name><name><surname>Calvo-Torrent</surname><given-names>A</given-names></name><name><surname>Herbert</surname><given-names>J</given-names></name></person-group><article-title>Mapping Brain Response to Social Stress in Rodents with C-Fos Expression: A Review</article-title><source>Stress</source><year>2002</year><volume>5</volume><issue>1</issue><fpage>3</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">12171762</pub-id></element-citation></ref><ref id="R35"><label>(35)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Numa</surname><given-names>C</given-names></name><name><surname>Nagai</surname><given-names>H</given-names></name><name><surname>Taniguchi</surname><given-names>M</given-names></name><name><surname>Nagai</surname><given-names>M</given-names></name><name><surname>Shinohara</surname><given-names>R</given-names></name><name><surname>Furuyashiki</surname><given-names>T</given-names></name></person-group><article-title>Social Defeat Stress-Specific Increase in c-Fos Expression in the Extended Amygdala in Mice: Involvement of Dopamine D1 Receptor in the Medial Prefrontal Cortex</article-title><source>Sci Rep</source><year>2019</year><volume>9</volume><issue>1</issue><elocation-id>16670</elocation-id><pub-id pub-id-type="pmcid">PMC6854085</pub-id><pub-id pub-id-type="pmid">31723165</pub-id><pub-id pub-id-type="doi">10.1038/s41598-019-52997-7</pub-id></element-citation></ref><ref id="R36"><label>(36)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardner</surname><given-names>KL</given-names></name><name><surname>Thrivikraman</surname><given-names>KV</given-names></name><name><surname>Lightman</surname><given-names>SL</given-names></name><name><surname>Plotsky</surname><given-names>PM</given-names></name><name><surname>Lowry</surname><given-names>CA</given-names></name></person-group><article-title>Early Life Experience Alters Behavior during Social Defeat: Focus on Serotonergic Systems</article-title><source>Neuroscience</source><year>2005</year><volume>136</volume><issue>1</issue><fpage>181</fpage><lpage>191</lpage><pub-id pub-id-type="pmid">16182451</pub-id></element-citation></ref><ref id="R37"><label>(37)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lino-de-Oliveira</surname><given-names>C</given-names></name><name><surname>de Oliveira</surname><given-names>RMW</given-names></name><name><surname>Pádua Carobrez</surname><given-names>A</given-names></name><name><surname>de Lima</surname><given-names>TCM</given-names></name><name><surname>Del Bel</surname><given-names>EA</given-names></name><name><surname>Guimarães</surname><given-names>FS</given-names></name></person-group><article-title>Antidepressant Treatment Reduces Fos-like Immunoreactivity Induced by Swim Stress in Different Columns of the Periaqueductal Gray Matter</article-title><source>Brain Res Bull</source><year>2006</year><volume>70</volume><issue>4–6</issue><fpage>414</fpage><lpage>421</lpage><pub-id pub-id-type="pmid">17027777</pub-id></element-citation></ref><ref id="R38"><label>(38)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paul</surname><given-names>ED</given-names></name><name><surname>Johnson</surname><given-names>PL</given-names></name><name><surname>Shekhar</surname><given-names>A</given-names></name><name><surname>Lowry</surname><given-names>CA</given-names></name></person-group><article-title>The Deakin/Graeff Hypothesis: Focus on Serotonergic Inhibition of Panic</article-title><source>Neurosci Biobehav Rev</source><year>2014</year><volume>46</volume><issue>P3</issue><fpage>379</fpage><lpage>396</lpage><pub-id pub-id-type="pmcid">PMC4170046</pub-id><pub-id pub-id-type="pmid">24661986</pub-id><pub-id pub-id-type="doi">10.1016/j.neubiorev.2014.03.010</pub-id></element-citation></ref><ref id="R39"><label>(39)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deakin</surname><given-names>JFW</given-names></name><name><surname>Graeff</surname><given-names>FG</given-names></name></person-group><article-title>5-HT and Mechanisms of Defence</article-title><source>Journal of Psychopharmacology</source><year>1991</year><volume>5</volume><issue>4</issue><fpage>305</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">22282829</pub-id></element-citation></ref><ref id="R40"><label>(40)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Commons</surname><given-names>KG</given-names></name><name><surname>Cholanians</surname><given-names>AB</given-names></name><name><surname>Babb</surname><given-names>JA</given-names></name><name><surname>Ehlinger</surname><given-names>DG</given-names></name></person-group><article-title>The Rodent Forced Swim Test Measures Stress-Coping Strategy, Not Depression-like Behavior</article-title><source>ACS Chem Neurosci</source><year>2017</year><volume>8</volume><issue>5</issue><fpage>955</fpage><lpage>960</lpage><pub-id pub-id-type="pmcid">PMC5518600</pub-id><pub-id pub-id-type="pmid">28287253</pub-id><pub-id pub-id-type="doi">10.1021/acschemneuro.7b00042</pub-id></element-citation></ref><ref id="R41"><label>(41)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>APR</given-names></name><name><surname>Vieira</surname><given-names>C</given-names></name><name><surname>Bohner</surname><given-names>LOL</given-names></name><name><surname>Silva</surname><given-names>CF</given-names></name><name><surname>da Santos</surname><given-names>ECS</given-names></name><name><surname>De Lima</surname><given-names>TCM</given-names></name><name><surname>Lino-de-Oliveira</surname><given-names>C</given-names></name></person-group><article-title>A Proposal for Refining the Forced Swim Test in Swiss Mice</article-title><source>Prog Neuropsychopharmacol Biol Psychiatry</source><year>2013</year><volume>45</volume><fpage>150</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">23665107</pub-id></element-citation></ref><ref id="R42"><label>(42)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perona</surname><given-names>MTG</given-names></name><name><surname>Waters</surname><given-names>S</given-names></name><name><surname>Hall</surname><given-names>FS</given-names></name><name><surname>Sora</surname><given-names>I</given-names></name><name><surname>Lesch</surname><given-names>KP</given-names></name><name><surname>Murphy</surname><given-names>DL</given-names></name><name><surname>Caron</surname><given-names>M</given-names></name><name><surname>Uhl</surname><given-names>GR</given-names></name></person-group><article-title>Animal Models of Depression in Dopamine, Serotonin, and Norepinephrine Transporter Knockout Mice: Prominent Effects of Dopamine Transporter Deletions</article-title><source>Behavioural Pharmacology</source><year>2008</year><volume>19</volume><issue>5–6</issue><fpage>566</fpage><lpage>574</lpage><pub-id pub-id-type="pmcid">PMC2644662</pub-id><pub-id pub-id-type="pmid">18690111</pub-id><pub-id pub-id-type="doi">10.1097/FBP.0b013e32830cd80f</pub-id></element-citation></ref><ref id="R43"><label>(43)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carratalá-Ros</surname><given-names>C</given-names></name><name><surname>López-Cruz</surname><given-names>L</given-names></name><name><surname>Martínez-Verdú</surname><given-names>A</given-names></name><name><surname>Olivares-García</surname><given-names>R</given-names></name><name><surname>Salamone</surname><given-names>JD</given-names></name><name><surname>Correa</surname><given-names>M</given-names></name></person-group><article-title>Impact of Fluoxetine on Behavioral Invigoration of Appetitive and Aversively Motivated Responses: Interaction With Dopamine Depletion</article-title><source>Front Behav Neurosci</source><year>2021</year><volume>15</volume><elocation-id>700182</elocation-id><pub-id pub-id-type="pmcid">PMC8298758</pub-id><pub-id pub-id-type="pmid">34305547</pub-id><pub-id pub-id-type="doi">10.3389/fnbeh.2021.700182</pub-id></element-citation></ref><ref id="R44"><label>(44)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucki</surname><given-names>I</given-names></name><name><surname>Dalvi</surname><given-names>A</given-names></name><name><surname>Mayorga</surname><given-names>AJ</given-names></name></person-group><article-title>Sensitivity to the Effects of Pharmacologically Selective Antidepressants in Different Strains of Mice</article-title><source>Psychopharmacology (Berl)</source><year>2001</year><volume>155</volume><issue>3</issue><fpage>315</fpage><lpage>322</lpage><pub-id pub-id-type="pmid">11432695</pub-id></element-citation></ref><ref id="R45"><label>(45)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>M</given-names></name><name><surname>He</surname><given-names>T</given-names></name><name><surname>Meng</surname><given-names>QY</given-names></name><name><surname>Broussard</surname><given-names>JI</given-names></name><name><surname>Yao</surname><given-names>L</given-names></name><name><surname>Diao</surname><given-names>Y</given-names></name><name><surname>Sang</surname><given-names>XB</given-names></name><name><surname>Liu</surname><given-names>QP</given-names></name><name><surname>Liao</surname><given-names>YJ</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name></person-group><article-title>Immobility Responses between Mouse Strains Correlate with Distinct Hippocampal Serotonin Transporter Protein Expression and Function</article-title><source>International Journal of Neuropsychopharmacology</source><year>2014</year><volume>17</volume><issue>11</issue><fpage>1737</fpage><lpage>1750</lpage><pub-id pub-id-type="pmid">24833265</pub-id></element-citation></ref><ref id="R46"><label>(46)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>ZL</given-names></name><name><surname>Chen</surname><given-names>XF</given-names></name><name><surname>Ran</surname><given-names>YH</given-names></name><name><surname>Li</surname><given-names>XR</given-names></name><name><surname>Xiong</surname><given-names>J</given-names></name><name><surname>Zheng</surname><given-names>YY</given-names></name><name><surname>Gao</surname><given-names>NN</given-names></name><name><surname>Li</surname><given-names>YF</given-names></name></person-group><article-title>Mouse Strain Differences in SSRI Sensitivity Correlate with Serotonin Transporter Binding and Function</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><issue>1</issue><elocation-id>8631</elocation-id><pub-id pub-id-type="pmcid">PMC5561191</pub-id><pub-id pub-id-type="pmid">28819255</pub-id><pub-id pub-id-type="doi">10.1038/s41598-017-08953-4</pub-id></element-citation></ref><ref id="R47"><label>(47)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sunal</surname><given-names>R</given-names></name><name><surname>Gümüşel</surname><given-names>B</given-names></name><name><surname>Kayaalp</surname><given-names>SO</given-names></name></person-group><article-title>Effect of Changes in Swimming Area on Results of “Behavioral Despair Test.”</article-title><source>Pharmacol Biochem Behav</source><year>1994</year><volume>49</volume><issue>4</issue><fpage>891</fpage><lpage>896</lpage><pub-id pub-id-type="pmid">7886103</pub-id></element-citation></ref><ref id="R48"><label>(48)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosas-Sánchez</surname><given-names>GU</given-names></name><name><surname>German-Ponciano</surname><given-names>LJ</given-names></name><name><surname>Rodríguez-Landa</surname><given-names>JF</given-names></name></person-group><article-title>Considerations of Pool Dimensions in the Forced Swim Test in Predicting the Potential Antidepressant Activity of Drugs</article-title><source>Front Behav Neurosci</source><year>2022</year><volume>15</volume><pub-id pub-id-type="pmcid">PMC8777187</pub-id><pub-id pub-id-type="pmid">35069137</pub-id><pub-id pub-id-type="doi">10.3389/fnbeh.2021.757348</pub-id></element-citation></ref><ref id="R49"><label>(49)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>AG</given-names></name><name><surname>Jocham</surname><given-names>G</given-names></name><name><surname>Ullsperger</surname><given-names>M</given-names></name></person-group><article-title>Dual Serotonergic Signals: A Key to Understanding Paradoxical Effects?</article-title><source>Trends Cogn Sci</source><year>2015</year><volume>19</volume><issue>1</issue><fpage>21</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">25532701</pub-id></element-citation></ref><ref id="R50"><label>(50)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trudeau</surname><given-names>LE</given-names></name><name><surname>El Mestikawy</surname><given-names>S</given-names></name></person-group><article-title>Glutamate Cotransmission in Cholinergic, GABAergic and Monoamine Systems: Contrasts and Commonalities</article-title><source>Front Neural Circuits</source><year>2018</year><volume>12</volume><fpage>113</fpage><pub-id pub-id-type="pmcid">PMC6305298</pub-id><pub-id pub-id-type="pmid">30618649</pub-id><pub-id pub-id-type="doi">10.3389/fncir.2018.00113</pub-id></element-citation></ref><ref id="R51"><label>(51)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Mestikawy</surname><given-names>S</given-names></name><name><surname>Wallén-Mackenzie</surname><given-names>Å</given-names></name><name><surname>Fortin</surname><given-names>GM</given-names></name><name><surname>Descarries</surname><given-names>L</given-names></name><name><surname>Trudeau</surname><given-names>L-E</given-names></name></person-group><article-title>From Glutamate Co-Release to Vesicular Synergy: Vesicular Glutamate Transporters</article-title><source>Nat Rev Neurosci</source><year>2011</year><volume>12</volume><issue>4</issue><fpage>204</fpage><lpage>216</lpage><pub-id pub-id-type="pmid">21415847</pub-id></element-citation></ref><ref id="R52"><label>(52)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prakash</surname><given-names>N</given-names></name><name><surname>Stark</surname><given-names>CJ</given-names></name><name><surname>Keisler</surname><given-names>MN</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Der-Avakian</surname><given-names>A</given-names></name><name><surname>Dulcis</surname><given-names>D</given-names></name></person-group><article-title>Serotonergic Plasticity in the Dorsal Raphe Nucleus Characterizes Susceptibility and Resilience to Anhedonia</article-title><source>J Neurosci</source><year>2020</year><volume>40</volume><issue>3</issue><fpage>569</fpage><lpage>584</lpage><pub-id pub-id-type="pmcid">PMC6961996</pub-id><pub-id pub-id-type="pmid">31792153</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1802-19.2019</pub-id></element-citation></ref><ref id="R53"><label>(53)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H-Q</given-names></name><name><surname>Jiang</surname><given-names>W</given-names></name><name><surname>Ling</surname><given-names>L</given-names></name><name><surname>Gupta</surname><given-names>V</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Pratelli</surname><given-names>M</given-names></name><name><surname>Godavarthi</surname><given-names>SK</given-names></name><name><surname>Spitzer</surname><given-names>NC</given-names></name></person-group><article-title>Generalized Fear Following Acute Stress Is Caused by Change in Co-Transmitter Identity of Serotonergic Neurons</article-title><source>bioRxiv</source><year>2023</year></element-citation></ref><ref id="R54"><label>(54)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gras</surname><given-names>C</given-names></name><name><surname>Vinatier</surname><given-names>J</given-names></name><name><surname>Amilhon</surname><given-names>B</given-names></name><name><surname>Guerci</surname><given-names>A</given-names></name><name><surname>Christov</surname><given-names>C</given-names></name><name><surname>Ravassard</surname><given-names>P</given-names></name><name><surname>Giros</surname><given-names>B</given-names></name><name><surname>El Mestikawy</surname><given-names>S</given-names></name></person-group><article-title>Developmentally Regulated Expression of VGLUT3 during Early Post-Natal Life</article-title><source>Neuropharmacology</source><year>2005</year><volume>49</volume><issue>6</issue><fpage>901</fpage><lpage>911</lpage><pub-id pub-id-type="pmid">16182324</pub-id></element-citation></ref><ref id="R55"><label>(55)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boulland</surname><given-names>JL</given-names></name><name><surname>Qureshi</surname><given-names>T</given-names></name><name><surname>Seal</surname><given-names>RP</given-names></name><name><surname>Rafiki</surname><given-names>A</given-names></name><name><surname>Gundersen</surname><given-names>V</given-names></name><name><surname>Bergersen</surname><given-names>LH</given-names></name><name><surname>Fremeau</surname><given-names>RT</given-names></name><name><surname>Edwards</surname><given-names>RH</given-names></name><name><surname>Storm-Mathisen</surname><given-names>J</given-names></name><name><surname>Chaudhry</surname><given-names>FA</given-names></name></person-group><article-title>Expression of the Vesicular Glutamate Transporters during Development Indicates the Widespread Corelease of Multiple Neurotransmitters</article-title><source>Journal of Comparative Neurology</source><year>2004</year><volume>480</volume><issue>3</issue><fpage>264</fpage><lpage>280</lpage><pub-id pub-id-type="pmid">15515175</pub-id></element-citation></ref><ref id="R56"><label>(56)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramet</surname><given-names>L</given-names></name><name><surname>Zimmermann</surname><given-names>J</given-names></name><name><surname>Bersot</surname><given-names>T</given-names></name><name><surname>Poirel</surname><given-names>O</given-names></name><name><surname>De Gois</surname><given-names>S</given-names></name><name><surname>Silm</surname><given-names>K</given-names></name><name><surname>Sakae</surname><given-names>DY</given-names></name><name><surname>Mansouri-Guilani</surname><given-names>N</given-names></name><name><surname>Bourque</surname><given-names>MJ</given-names></name><name><surname>Trudeau</surname><given-names>LE</given-names></name><name><surname>Pietrancosta</surname><given-names>N</given-names></name><etal/></person-group><article-title>Characterization of a Human Point Mutation of VGLUT3 (p.A211V) in the Rodent Brain Suggests a Nonuniform Distribution of the Transporter in Synaptic Vesicles</article-title><source>Journal of Neuroscience</source><year>2017</year><volume>37</volume><issue>15</issue><fpage>4181</fpage><lpage>4199</lpage><pub-id pub-id-type="pmcid">PMC6596587</pub-id><pub-id pub-id-type="pmid">28314816</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0282-16.2017</pub-id></element-citation></ref><ref id="R57"><label>(57)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gouveia</surname><given-names>K</given-names></name><name><surname>Hurst</surname><given-names>JL</given-names></name></person-group><article-title>Improving the Practicality of Using Non-Aversive Handling Methods to Reduce Background Stress and Anxiety in Laboratory Mice</article-title><source>Sci Rep</source><year>2019</year><volume>9</volume><issue>1</issue><elocation-id>20305</elocation-id><pub-id pub-id-type="pmcid">PMC6937263</pub-id><pub-id pub-id-type="pmid">31889107</pub-id><pub-id pub-id-type="doi">10.1038/s41598-019-56860-7</pub-id></element-citation></ref><ref id="R58"><label>(58)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porsolt</surname><given-names>RD</given-names></name><name><surname>Le Pichon</surname><given-names>M</given-names></name><name><surname>Jalfre</surname><given-names>M</given-names></name></person-group><article-title>Depression: A New Animal Model Sensitive to Antidepressant Treatments</article-title><source>Nature</source><year>1977</year><volume>266</volume><issue>5604</issue><fpage>730</fpage><lpage>732</lpage><pub-id pub-id-type="pmid">559941</pub-id></element-citation></ref><ref id="R59"><label>(59)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bogdanova</surname><given-names>OV</given-names></name><name><surname>Kanekar</surname><given-names>S</given-names></name><name><surname>D’Anci</surname><given-names>KE</given-names></name><name><surname>Renshaw</surname><given-names>PF</given-names></name></person-group><article-title>Factors Influencing Behavior in the Forced Swim Test</article-title><source>Physiol Behav</source><year>2013</year><volume>118</volume><fpage>227</fpage><lpage>239</lpage><pub-id pub-id-type="pmcid">PMC5609482</pub-id><pub-id pub-id-type="pmid">23685235</pub-id><pub-id pub-id-type="doi">10.1016/j.physbeh.2013.05.012</pub-id></element-citation></ref><ref id="R60"><label>(60)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovács</surname><given-names>KJ</given-names></name></person-group><article-title>Invited Review C-Fos as a Transcription Factor: A Stressful (Re)View from a Functional Map</article-title><source>Neurochem Int</source><year>1998</year><volume>33</volume><issue>4</issue><fpage>287</fpage><lpage>297</lpage><pub-id pub-id-type="pmid">9840219</pub-id></element-citation></ref><ref id="R61"><label>(61)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golden</surname><given-names>SA</given-names></name><name><surname>Covington</surname><given-names>HE</given-names></name><name><surname>Berton</surname><given-names>O</given-names></name><name><surname>Russo</surname><given-names>SJ</given-names></name></person-group><article-title>A Standardized Protocol for Repeated Social Defeat Stress in Mice</article-title><source>Nat Protoc</source><year>2011</year><volume>6</volume><issue>8</issue><fpage>1183</fpage><lpage>1191</lpage><pub-id pub-id-type="pmcid">PMC3220278</pub-id><pub-id pub-id-type="pmid">21799487</pub-id><pub-id pub-id-type="doi">10.1038/nprot.2011.361</pub-id></element-citation></ref><ref id="R62"><label>(62)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sengupta</surname><given-names>A</given-names></name><name><surname>Holmes</surname><given-names>A</given-names></name></person-group><article-title>A Discrete Dorsal Raphe to Basal Amygdala 5-HT Circuit Calibrates Aversive Memory</article-title><source>Neuron</source><year>2019</year><volume>103</volume><issue>3</issue><fpage>489</fpage><lpage>505</lpage><elocation-id>e7</elocation-id><pub-id pub-id-type="pmcid">PMC6687558</pub-id><pub-id pub-id-type="pmid">31204082</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2019.05.029</pub-id></element-citation></ref><ref id="R63"><label>(63)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rio</surname><given-names>DC</given-names></name><name><surname>Ares</surname><given-names>M</given-names></name><name><surname>Hannon</surname><given-names>GJ</given-names></name><name><surname>Nilsen</surname><given-names>TW</given-names></name></person-group><article-title>Purification of RNA Using TRIzol (TRI Reagent)</article-title><source>Cold Spring Harb Protoc</source><year>2010</year><volume>2010</volume><issue>6</issue><comment>pdb-prot5439</comment><pub-id pub-id-type="pmid">20516177</pub-id></element-citation></ref><ref id="R64"><label>(64)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radford-Smith</surname><given-names>DE</given-names></name><name><surname>Probert</surname><given-names>F</given-names></name><name><surname>Burnet</surname><given-names>PWJ</given-names></name><name><surname>Anthony</surname><given-names>DC</given-names></name></person-group><article-title>Modifying the Maternal Microbiota Alters the Gut–Brain Metabolome and Prevents Emotional Dysfunction in the Adult Offspring of Obese Dams</article-title><source>Proceedings of the National Academy of Sciences</source><year>2022</year><volume>119</volume><issue>9</issue><elocation-id>e2108581119</elocation-id><pub-id pub-id-type="pmcid">PMC8892342</pub-id><pub-id pub-id-type="pmid">35197280</pub-id><pub-id pub-id-type="doi">10.1073/pnas.2108581119</pub-id></element-citation></ref><ref id="R65"><label>(65)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>DY</given-names></name><name><surname>Hong</surname><given-names>S</given-names></name><name><surname>Jeong</surname><given-names>JW</given-names></name><name><surname>Choi</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>KS</given-names></name></person-group><article-title>Vesicular Monoamine Transporter 2 and Dopamine Transporter Are Molecular Targets of Pitx3 in the Ventral Midbrain Dopamine Neurons</article-title><source>J Neurochem</source><year>2009</year><volume>111</volume><issue>5</issue><fpage>1202</fpage><lpage>1212</lpage><pub-id pub-id-type="pmcid">PMC4896488</pub-id><pub-id pub-id-type="pmid">19780901</pub-id><pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.06404.x</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>C-Fos immunoreactivity in mouse midbrain following acute swim stress.</title><p id="P49">(A) C-Fos immunoreactivity in a midbrain section at the level of the DRN and MRN (left) according to the stereotaxic atlas (top right) of <sup><xref ref-type="bibr" rid="R26">26</xref></sup>. Higher magnification images of DRN subregions (bottom right). (B) High magnification images of c-Fos immunoreactivity in the ventral DRN of control mice, and mice administered a single injection of either saline or fluoxetine (FLX) and exposed to swim stress. Abbreviations: dorsal raphe nucleus (DRN), median raphe nucleus (MRN), aqueduct (Aq), medial longitudinal fasciculus (mlf).</p></caption><graphic xlink:href="EMS191784-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>Effect of acute swim stress, with or without fluoxetine, on c-Fos expression in midbrain subregions.</title><p id="P50">(A) C-Fos immunoreactive neurons in the DRN and MRN. (B) C-Fos immunoreactive neurons in DRN subregions. Columns are mean ± SEM values with individual values indicated by closed circles. ** p&lt;0.01 *p&lt;0.05. Groups were control (n=6), saline + swim stress (n=7) and 10 mg/kg fluoxetine + swim stress (n=7). Abbreviations as in <xref rid="F1" ref-type="fig">Fig. 1</xref>.</p></caption><graphic xlink:href="EMS191784-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>Effect of swim stress, with or without fluoxetine, on c-Fos expression in DRN neurons co-expressing TPH2 and VGLUT3 in the ventral DRN.</title><p id="P51">(A) Representative image of c-Fos/TPH2/VGLUT3 triple-labelled neurons in the ventral DRN (AP= -4.6mm). (B) Effect of swim stress on number of c-Fos/TPH2 double-labelled neurons (left), c-Fos/TPH2/VGLUT3 triple-labelled neurons (middle), and c-Fos/TPH2 double-labelled neurons but VGLUT3 immunonegative (right). Columns represent the mean ± SEM values, with individual values indicated by closed circles. * p&lt;0.05. Groups were control (n=6), saline + swim stress (n=7) and 10 mg/kg fluoxetine + swim stress (n=7). Abbreviations as in <xref rid="F1" ref-type="fig">Fig. 1</xref>.</p></caption><graphic xlink:href="EMS191784-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>Effect of acute social defeat on c-Fos immunoreactive neurons in DRN, including neurons co-labelled with TPH2 and VGLUT3.</title><p id="P52">(A) C-Fos immunoreactive neurons in DRN subregions. (B) C-Fos/TPH2 double-labelled neurons (left), c-Fos/TPH2/VGLUT3 triple-labelled neurons (middle), and c-Fos/TPH2 double-labelled neurons immunonegative for VGLUT3 (right) in the ventral DRN. Columns represent mean ± SEM values, with individual values indicated by closed circles. Groups were non-stressed controls (n=8) and social defeat (n=7). Abbreviations as in <xref rid="F1" ref-type="fig">Fig. 1</xref>.</p></caption><graphic xlink:href="EMS191784-f004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><title>Effect of acute social defeat and swim stress on c-Fos immunoreactive neurons in the PAG.</title><p id="P53">A) C-Fos immunoreactive cells in the PAG following social defeat (n=7) versus non-stressed controls (n=8). (B) C-Fos immunoreactive cells in the PAG following swim stress (n=7), swim stress with fluoxetine (n=7) versus non-stressed controls (n=6). Columns represent mean ± SEM values, with individual values indicated by closed circles. **** p&lt;0.0001 *** p&lt;0.001 ** p&lt;0.01 * p&lt;0.05.</p></caption><graphic xlink:href="EMS191784-f005"/></fig><fig id="F6" position="float"><label>Figure 6</label><caption><title>VGLUT3 cKO<sup>5-HT</sup> mice; molecular characterisation and behavioural response to swim stress.</title><p id="P54">(A) Representative image of TPH2/VGLUT3 double-labelled neurons (white arrows) in the ventral DRN of control mice (top) and VGLUT3 cKO<sup>5-HT</sup> (bottom). (B) VGLUT3 and VMAT2 mRNA in the midbrain raphe region of VGLUT3 cKO<sup>5-HT</sup> mice and littermate controls. (C) Number of TPH2/VGLUT3 co-labelled neurons (left) and TPH2 neurons (right) in the ventral DRN of VGLUT3 cKO<sup>5-HT</sup> mice and littermate controls. (D) Performance of VGLUT3 cKO<sup>5-HT</sup> mice (n=19-20) and littermate controls (n=15) during swim stress exposure. Columns are mean ± SEM values, except for climbing and immobility data that are medians with interquartile ranges. Individual values are indicated by closed circles. **** p&lt;0.0001 ** p&lt;0.01 * p&lt;0.05.</p></caption><graphic xlink:href="EMS191784-f006"/></fig><fig id="F7" position="float"><label>Figure 7</label><caption><title>Experimental timeline.</title><p id="P55">(A) Timeline of swim stress (top) and social defeat (below) experiments. Abbreviations: fluoxetine (FLX), dorsal raphe nucleus (DRN). Created with BioRender.com.</p></caption><graphic xlink:href="EMS191784-f007"/></fig></floats-group></article>